Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07107880 · ClinicalTrials.gov registry record · NA
Use of Artificial Intelligence to Assess Trainee Communication Compared to Human Assessment
A NA study, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07107880: Recruiting NA study, sponsored by Stanford University.
NCT07107880 is a NA study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07107880, a NA study, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study will evaluate whether a web-based artificial intelligence platform (AI) (Clinical Mind AI \[CMAI\] Stanford, CA), can assess communication skills in anesthesiology trainees, including residents and fellows, in the setting of disclosing medical errors. All participants will participate in an AI-generated simulation by using the platform remotely, and CMAI will assess trainee performance immediately after the simulation.
Primary Outcome
The primary outcome is to evaluate the reliability of the Clinical Mind AI (CMAI) platform in accurately assessing the communication skills of medical education trainees during a simulated interaction. To measure this outcome, the CMAI will use the Breaking Bad News Assessment Schedule (BBAS), a validated tool assessing participant's communication skills in five domains: 1) Setting the scene, 2) Breaking the news, 3) Eliciting concerns, 4) Informative giving, and 5) Empathy and Support. It inclu
Interventions
- OTHER Communication Assessment through AI and Human
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-11-10 |
| Est. Completion | 2026-11-14 |
| Phase | NA |
What NCT07107880 shows while recruiting
NCT07107880 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Communication Assessment through AI and Human is the first listed.
NCT07107880 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07107880 about?
NCT07107880 is a clinical study titled "Use of Artificial Intelligence to Assess Trainee Communication Compared to Human Assessment". This study will evaluate whether a web-based artificial intelligence platform (AI) (Clinical Mind AI \[CMAI\] Stanford, CA), can assess communication skills in anesthesiology trainees, including residents and fellows, in the setting of disclosing medical errors. All participants will participate in ...
What is the current status of trial NCT07107880?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-11-10. Estimated completion is 2026-11-14.
What interventions are being tested in trial NCT07107880?
The interventions under investigation include: Communication Assessment through AI and Human (OTHER).
Who is sponsoring clinical trial NCT07107880?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07107880's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI